Two Sigma Advisers
NERV icon

Two Sigma Advisers’s Minerva Neurosciences NERV Stock Holding History

Two Sigma Advisers’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-31,060
Closed -$576K – 2603
2021
Q2 		$576K Sell
31,060
-36,390
-54% -$783K ﹤0.01% 1882
2021
Q1 		$1.58M Sell
67,450
-4,000
-6% -$99.9K ﹤0.01% 1391
2020
Q4 		$1.34M Buy
71,450
+29,287
+69% +$738K ﹤0.01% 1443
2020
Q3 		$1.07M Buy
42,163
+35,800
+563% +$968K ﹤0.01% 1478
2020
Q2 		$184K Buy
6,363
+4,338
+214% +$254K ﹤0.01% 2268
2020
Q1 		$98K Buy
+2,025
New +$122K ﹤0.01% 2302

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's NERV Position: Q3 2021 in Review

Two Sigma Advisers sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 31,060 shares — an estimated $576K sold.

Two Sigma Advisers first reported a position in NERV in Q1 2020 and held it in 6 quarters. The position peaked at $1.58M in Q1 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Two Sigma Advisers reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 31,060 Minerva Neurosciences shares in Q3 2021, an estimated $576K.
  • Two Sigma Advisers first reported a position in Minerva Neurosciences in Q1 2020 and held it in 6 quarters.
  • Two Sigma Advisers's Minerva Neurosciences position peaked at $1.58M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.